ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AMRS Amyris Inc

0.05
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Amyris Inc NASDAQ:AMRS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.05 0.053 0.054 0 01:00:00

Amended Current Report Filing (8-k/a)

20/11/2020 10:09pm

Edgar (US Regulatory)


0001365916TRUEAmyris, Inc. (the “Company”) is filing this Amendment No. 2 on Form 8-K/A to the Company’s Current Report on Form 8-K (“Form 8-K”) filed with the Securities and Exchange Commission (the “SEC”) on May 20, 2019 which reported, among other things, the appointment of James McCann as a member of the Company’s Board of Directors (the “Board”) and which was amended on October 2, 2020 to report, among other things, the appointment of Mr. McCann as a member of the Audit Committee of the Board.00013659162019-05-142019-05-14

 
 
 
 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
     
 
 
FORM 8-K/A
 (Amendment No. 2)
Current Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

____________________


Date of report (Date of earliest event reported): May 14, 2019
 
Amyris, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware 001-34885 55-0856151
(State or other jurisdiction
of incorporation)
(Commission File Number)
(I.R.S. Employer
Identification No.)
 
 
5885 Hollis Street, Suite 100,  Emeryville, CA 94608    
(Address of Principal Executive Offices) (Zip Code)
 
 
  (510) 450-0761  
  (Registrant’s telephone number, including area code)
     
  (Former name or former address, if changed since last report.)  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):



Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
  Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.0001 par value per share AMRS The Nasdaq Stock Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 
EXPLANATORY NOTE

Amyris, Inc. (the “Company”) is filing this Amendment No. 2 on Form 8-K/A to the Company’s Current Report on Form 8-K (“Form 8-K”) filed with the Securities and Exchange Commission (the “SEC”) on May 20, 2019 which reported, among other things, the appointment of James McCann as a member of the Company’s Board of Directors (the “Board”) and which was amended on October 2, 2020 to report, among other things, the appointment of Mr. McCann as a member of the Audit Committee of the Board.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

On and effective as of November 17, 2020, upon recommendation by the Board’s Nominating and Governance Committee, the Board appointed Mr. McCann to the Operations and Finance Committee of the Board.

Item 9.01    Financial Statements and Exhibits

(d) Exhibits
The following exhibits are furnished herewith:

Exhibit Number Description
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
    AMYRIS, INC.  
       
       
Date: November 20, 2020 By:  /s/ Nicole Kelsey  
    Nicole Kelsey  
    General Counsel and Secretary

1 Year Amyris Chart

1 Year Amyris Chart

1 Month Amyris Chart

1 Month Amyris Chart

Your Recent History

Delayed Upgrade Clock